scholarly journals Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis

2016 ◽  
Vol 47 (4) ◽  
pp. 1277-1280 ◽  
Author(s):  
Antoine Guillon ◽  
Fabien Gueugnon ◽  
Konstantinos Mavridis ◽  
Emilie Dalloneau ◽  
Youenn Jouan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Nonsmall Cell Lung Cancer ◽  
Interleukin 22

Genetic Polymorphisms and Plasma Levels of Interleukin-22 Contribute to the Development of Nonsmall Cell Lung Cancer

2014 ◽  
Vol 33 (10) ◽  
pp. 705-714 ◽  
Author(s):  
Fei Liu ◽  
Xufeng Pan ◽  
Lin Zhou ◽  
Jian Zhou ◽  
Bin Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Genetic Polymorphisms ◽  
Cell Lung Cancer ◽  
Plasma Levels ◽  
Nonsmall Cell Lung Cancer ◽  
Interleukin 22

Downregulation of Kruppel-like factor 2 is associated with poor prognosis for nonsmall-cell lung cancer

Tumor Biology ◽  
2014 ◽  
Vol 36 (4) ◽  
pp. 3075-3084 ◽  
Author(s):  
Li Yin ◽  
Ji-peng Wang ◽  
Tong-peng Xu ◽  
Wen-ming Chen ◽  
Ming-de Huang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Nonsmall Cell Lung Cancer

Downregulation of HDPR1 is associated with poor prognosis and affects expression levels of p120-catenin and β-catenin in nonsmall cell lung cancer

2010 ◽  
Vol 49 (5) ◽  
pp. 508-519 ◽  
Author(s):  
Zhi-Qiang Yang ◽  
Yue Zhao ◽  
Yang Liu ◽  
Jun-Yi Zhang ◽  
Sheng Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Nonsmall Cell Lung Cancer ◽  
P120 Catenin ◽  
Expression Levels

Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer

2010 ◽  
Vol 49 (10) ◽  
pp. 874-881 ◽  
Author(s):  
Po-Len Liu ◽  
Jong-Rung Tsai ◽  
Chien-Chih Chiu ◽  
Jhi-Jhu Hwang ◽  
Shah-Hwa Chou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tumor Cell ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Nonsmall Cell Lung Cancer ◽  
Cell Invasiveness

LIFE SPAN PREDICTION AT METASTATIC NON-SMALL CELL LUNG CANCER

2018 ◽  
Vol 64 (4) ◽  
pp. 522-527
Author(s):  
Aleksey Shutko ◽  
Viktor Mus
Keyword(s):  
Lung Cancer ◽  
Stem Cells ◽  
Small Cell Lung Cancer ◽  
Life Span ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Hemopoietic Stem Cells ◽  
Small Cell Lung ◽  
Individual Life

Individual parameters of circulating hemopoietic stem cells (HSC) lymphoid origin were measured by cytofluorometry before treatment of patients with metastatic non-small cell lung cancer and were retrospectively compared with individual life span's (LS). The possibility of poor prognosis of treatment's results (LS

Sign in / Sign up

Export Citation Format

Share Document